These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 30568232)
1. Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer. Choudhary S; Ramasundaram P; Dziopa E; Mannion C; Kissin Y; Tricoli L; Albanese C; Lee W; Zilberberg J Sci Rep; 2018 Dec; 8(1):17975. PubMed ID: 30568232 [TBL] [Abstract][Full Text] [Related]
2. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions. Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Hall CL; Bafico A; Dai J; Aaronson SA; Keller ET Cancer Res; 2005 Sep; 65(17):7554-60. PubMed ID: 16140917 [TBL] [Abstract][Full Text] [Related]
4. Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Hall CL; Daignault SD; Shah RB; Pienta KJ; Keller ET Prostate; 2008 Sep; 68(13):1396-404. PubMed ID: 18561248 [TBL] [Abstract][Full Text] [Related]
5. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts. Shokoohmand A; Ren J; Baldwin J; Atack A; Shafiee A; Theodoropoulos C; Wille ML; Tran PA; Bray LJ; Smith D; Chetty N; Pollock PM; Hutmacher DW; Clements JA; Williams ED; Bock N Biomaterials; 2019 Nov; 220():119402. PubMed ID: 31400612 [TBL] [Abstract][Full Text] [Related]
6. Effects of Dickkopf-1 (DKK-1) on Prostate Cancer Growth and Bone Metastasis. Yuan S; Hoggard NK; Kantake N; Hildreth BE; Rosol TJ Cells; 2023 Nov; 12(23):. PubMed ID: 38067123 [TBL] [Abstract][Full Text] [Related]
7. Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. Larson SR; Zhang X; Dumpit R; Coleman I; Lakely B; Roudier M; Higano CS; True LD; Lange PH; Montgomery B; Corey E; Nelson PS; Vessella RL; Morrissey C Prostate; 2013 Jun; 73(9):932-40. PubMed ID: 23334979 [TBL] [Abstract][Full Text] [Related]
8. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches. Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo construction of human primary 3D-networked osteocytes. Sun Q; Choudhary S; Mannion C; Kissin Y; Zilberberg J; Lee WY Bone; 2017 Dec; 105():245-252. PubMed ID: 28942121 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion. Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731 [TBL] [Abstract][Full Text] [Related]
11. Bone microenvironment-mediated resistance of cancer cells to bisphosphonates and impact on bone osteocytes/stem cells. Alasmari A; Lin SC; Dibart S; Salih E Clin Exp Metastasis; 2016 Aug; 33(6):563-88. PubMed ID: 27155840 [TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone. Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537 [TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
14. Osteocytes and Bone Metastasis. Riquelme MA; Cardenas ER; Jiang JX Front Endocrinol (Lausanne); 2020; 11():567844. PubMed ID: 33162934 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
16. Disruption of collagen/apatite alignment impairs bone mechanical function in osteoblastic metastasis induced by prostate cancer. Sekita A; Matsugaki A; Nakano T Bone; 2017 Apr; 97():83-93. PubMed ID: 28069516 [TBL] [Abstract][Full Text] [Related]
17. Hypoxic Three-Dimensional Cellular Network Construction Replicates Ex Vivo the Phenotype of Primary Human Osteocytes. Choudhary S; Sun Q; Mannion C; Kissin Y; Zilberberg J; Lee WY Tissue Eng Part A; 2018 Mar; 24(5-6):458-468. PubMed ID: 28594289 [TBL] [Abstract][Full Text] [Related]
18. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck. Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552 [TBL] [Abstract][Full Text] [Related]
19. TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases. Delliaux C; Tian TV; Bouchet M; Fradet A; Vanpouille N; Flourens A; Deplus R; Villers A; Leroy X; Clézardin P; de Launoit Y; Bonnelye E; Duterque-Coquillaud M Cancer Lett; 2018 Dec; 438():32-43. PubMed ID: 30201302 [TBL] [Abstract][Full Text] [Related]
20. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system. Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]